Published by ChinaMNC · Fugong

Yunnan’s 15th Five-Year Plan for Traditional Chinese Medicinal Materials: What Foreign Founders Need to Know

Yunnan Province has released a plan to reshape its traditional Chinese medicinal materials industry by 2030, focusing on quality, processing, and branding. For foreign founders, this signals opportunities in GAP bases, processing, and health products.

Yunnan’s New Direction for Traditional Chinese Medicinal Materials

Yunnan Province has published its 15th Five-Year Plan for the development of traditional Chinese medicinal materials (TCM), covering the period up to 2030. The plan, issued by the Yunnan Provincial People’s Government, sets a clear direction: reduce planted area while increasing quality, processing depth, branding, and overall value. For foreign founders considering entering China’s TCM or health-product sectors, this policy outlines where provincial support and regulatory attention will be focused.

Key Targets at a Glance

By 2030, the plan expects the total planted area for TCM materials in Yunnan to decrease by 1.608 million mu (approximately 107,200 hectares), while the comprehensive output value is targeted to increase by 50 billion yuan. This “reduction in area” is explicitly linked to “increases” in quality, processing, branding, and efficiency. The shift suggests a move away from volume-driven expansion toward higher-value production.

Priority Crop Categories

Building on the 156 varieties listed in the 2024 edition of Yunnan’s Dao-di (authentic) medicinal materials catalogue, the plan prioritizes three groups:

• Dao-di advantage varieties: the “Top Ten Yunnan Medicines,” represented by Panax notoginseng (sanqi), including such items as Yunnan heavy楼 (Paris polyphylla), Erigeron breviscapus, Dendrobium officinale, Amomum villosum, Gastrodia elata, Yunnan Poria, Yunnan Angelica, Yunnan Aucklandia, and Yunnan Gentiana.
• Health-characteristic varieties: the “Top Ten Health Resources,” mainly Polygonatum kingianum, safflower, Bletilla striata, purple Dendrobium, Phyllanthus emblica (Yunnan olive), Coix seed, Terminalia chebula, Amomum tsaoko, ginger, and star anise.
• Potential cultivation varieties: the “Six Southern Medicines,” represented by Amomum villosum, dragon’s blood, Cibotium barometz, agarwood, Orthosiphon aristatus, and Dai Bai Jie.

These categories indicate where the province sees comparative advantage and where foreign investors might find supply-chain partners or raw material sources.

Standardized Cultivation: GAP Bases

The plan aims to establish 200 Good Agricultural Practice (GAP) bases for TCM materials. A key focus is full GAP coverage for Wenshan sanqi bases. The plan also calls for orderly development of GAP bases for under-forest varieties such as Poria, Amomum villosum, Amomum tsaoko, and Phellodendron chinense. Additionally, it seeks to create a number of national-level high-standard raw material production bases. For foreign founders, GAP certification may become increasingly relevant for sourcing and for meeting quality expectations in export markets.

Under-Forest Cultivation

Focusing on Dao-di herbs such as sanqi, Gastrodia, Poria, Amomum villosum, Polygonatum, and Phellodendron, the plan promotes under-forest cultivation and breeding. Ecological and under-forest planting bases are to expand to more than 6 million mu (approximately 400,000 hectares). This approach may offer opportunities in sustainable sourcing and land-use partnerships.

Primary Processing at Origin

The plan supports establishing primary processing lines in Dao-di production areas and high-standard raw material bases. It encourages linking GAP-base materials with fresh-cut processing and upgrading products from raw materials to semi-industrial input materials. This could reduce logistics costs and improve traceability for companies that process or export TCM materials.

High-Value-Added Products

Enterprises are encouraged to build modern deep-processing lines and develop high-value-added products, forming a series of Yunnan medicine health products. The plan also promotes research and industrialization of health products in areas such as daily chemicals, cosmetics, and functional wellness. Foreign founders with expertise in these segments may find partnership or investment opportunities.

Market Stabilization and Risk Prevention

For bulk and scarce varieties susceptible to market fluctuations—such as sanqi, Angelica sinensis, and Paris polyphylla—the plan calls for market-based adjustment mechanisms to smooth price swings. It also includes building an information monitoring and early-warning system to guard against risks like “blind expansion” and “low prices hurting farmers.” This signals a more coordinated approach to supply management.

Food-Medicine Homology Development

The plan includes developing standards for food-medicine homologous raw materials and production processes, completing cross-border registration for 5–10 new products, and planning a “Yunnan Medicine Food-Medicine Homology Culture Festival.” For foreign companies in the health food sector, this could open avenues for product registration and cross-border e-commerce.

“Yunnan Medicine Brain” AI Project

An artificial intelligence innovation project called “Yunnan Medicine Brain” is to be implemented, building an intelligent application system covering the entire life cycle of TCM materials. The focus is on forming multi-level, multi-scenario intelligent solutions in key areas. This may create demand for tech-enabled services and data-driven solutions.

Practical Implications for Foreign Founders

If you are considering setting up a company in China to participate in the TCM or health-product sector, Yunnan’s plan offers several entry points:

• Sourcing and quality: GAP bases and standardized cultivation may improve supply reliability and quality documentation, which can be important for export and for meeting foreign regulatory requirements.
• Processing and value addition: Support for primary and deep processing suggests opportunities for joint ventures or wholly foreign-owned enterprises in processing.
• Health products and cosmetics: The push for high-value-added products and food-medicine homology could align with foreign brands seeking natural-ingredient products.
• Technology and services: The AI project and monitoring systems may create niches for foreign tech providers.

However, foreign investment in China involves specific registration, licensing, and compliance procedures. The plan itself does not change those requirements; it indicates provincial priorities that may affect incentives, land access, and regulatory support.

Next Steps

Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.